| Literature DB >> 28576493 |
Li-Li Pang1, Xin-Hui Yuan2, Chang-Sheng Shao3, Mao-Zhong Li4, Ying Wang5, Hui-Min Wang5, Guang-Cheng Xie6, Zhi-Ping Xie1, Yue Yuan5, Dong-Mei Zhou1, Xiao-Man Sun1, Qing Zhang1, Yan Xin7, Dan-di Li8, Zhao-Jun Duan9.
Abstract
Rhinovirus C (RV-C), a newly identified group of human rhinoviruses (RVs), is associated with exacerbation of severe asthma. The type I interferon (IFN) response induced by this virus and the mechanisms of evasion of IFN-mediated innate immunity for RV-C remain unclear. In this study, we constructed a full-length cDNA clone of RV-C (LZ651) from a clinical sample. IFN-β mRNA and protein levels were not elevated in differentiated Human bronchial epithelial (HBE) cells at the air-liquid interface infected with RV-C, except in the early stage of infection. The ability to attenuate IFN-β activation was ascribed to 3Cpro of RV-C, and the 40-His site of 3Cpro played an important role. Furthermore, RIG-I was degraded by 3Cpro in a caspase-dependent manner and 3Cpro cleaved MAVS at 148 Q/A, which inhibited IFN signaling. Taken together, our results demonstrate the mechanism by which RV-C circumvents the production of type I IFN in infected cells.Entities:
Keywords: 3C protein; Interferon response; MAVS; RIG-I signaling pathway; Rhinovirus C
Mesh:
Substances:
Year: 2017 PMID: 28576493 DOI: 10.1016/j.bbrc.2017.05.169
Source DB: PubMed Journal: Biochem Biophys Res Commun ISSN: 0006-291X Impact factor: 3.575